Acción 600380 JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Joincare Pharmaceutical Group Industry Co.,Ltd.

Acciones

600380

CNE000001816

Precio de cierre Shanghai S.E.
Otros sitios de cotización
 00:00:00 27/06/2024 		Varia. Cinco días. Varia. 1 de enero.
11,34 CNY -4,55 % Gráfico intradía de Joincare Pharmaceutical Group Industry Co.,Ltd. -6,82 % -8,77 %
13/06 China aprueba el fármaco antiasmático de Joincare MT
28/05 China aprueba el fármaco para el asma de la unidad de Joincare MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
China Approves Joincare's Anti-Asthma Drug
China Approves Joincare Unit's Asthma Drug
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint
Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study
Joincare Pharmaceutical Group's 2023 Profit Falls 4%; Shares Slide 4%
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug
Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with Joincare Pharmaceutical Group Industry Co., Ltd
Joincare Pharmaceutical, Guangzhou Fermion Technology Get Nod to Trial Analgesic Drug
Livzon Pharmaceutical to Continue Getting Services from Joincare Pharmaceutical
Joincare Pharma’s 210 Drugs Included in China's Medical Insurance Catalog
Joincare Gets Nod to Trial Pain Relief Drug
Joincare Pharma Shortlisted For China’s Drug Procurement Program
Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.
Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback announced on December 15, 2022 has closed with 49,706,643 shares, representing 2.61% for CNY 599.91 million.
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Joincare Pharma Unit Gets Go Signal from China for Phase 3 Trial of Endometriosis Drug
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 600380
  4. Noticias Joincare Pharmaceutical Group Industry Co.,Ltd.
  5. Otros idiomas